Al-Dalahmah, Osama http://orcid.org/0000-0002-3442-5459
Argenziano, Michael G.
Kannan, Adithya http://orcid.org/0000-0001-7359-184X
Mahajan, Aayushi
Furnari, Julia
Paryani, Fahad
Boyett, Deborah
Save, Akshay
Humala, Nelson
Khan, Fatima
Li, Juncheng
Lu, Hong
Sun, Yu
Tuddenham, John F. http://orcid.org/0000-0002-0186-2652
Goldberg, Alexander R. http://orcid.org/0000-0002-0654-2199
Dovas, Athanassios
Banu, Matei A.
Sudhakar, Tejaswi
Bush, Erin
Lassman, Andrew B.
McKhann, Guy M.
Gill, Brian J. A.
Youngerman, Brett http://orcid.org/0000-0002-4792-3190
Sisti, Michael B.
Bruce, Jeffrey N. http://orcid.org/0000-0002-6844-0286
Sims, Peter A.
Menon, Vilas http://orcid.org/0000-0002-4096-8601
Canoll, Peter http://orcid.org/0000-0002-7001-0226
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS103473)
Article History
Received: 4 July 2021
Accepted: 20 April 2023
First Online: 4 May 2023
Competing interests
: P.A.S. receives patent royalties from Guardant Health. Columbia University has filed a patent application on the microwell single-cell RNA-seq technology used in this study, and P.A.S. is listed as a co-inventor. The patent number is WO/2016/191533. The patent title is “RNA printing and sequencing devices, methods, and systems”. None of the other authors declare any competing interests.